The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas

International Journal of Cancer

Volumn 135, Issue 2, 2014, Pages 362-370

  Szkandera, Joanna ^a   Gerger, Armin ^a   Liegl Atzwanger, Bernadette ^a   Absenger, Gudrun ^a   Stotz, Michael ^a   Friesenbichler, Joerg ^a   Trajanoski, Slave ^a   Stojakovic, Tatjana ^a   Eberhard, Katharina ^a   Leithner, Andreas ^a   Pichler, Martin ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

biomarker; inflammation; prognosis; soft tissue sarcoma

Indexed keywords

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CELLULAR PARAMETERS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPHOCYTE MONOCYTE RATIO; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; NOMOGRAM; OVERALL SURVIVAL; PLATELET LYMPHOCYTE RATIO; PRIORITY JOURNAL; RISK ASSESSMENT; SOFT TISSUE SARCOMA; SURVIVAL PREDICTION;

BIOMARKER; INFLAMMATION; PROGNOSIS; SOFT TISSUE SARCOMA;

AGED; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKOCYTE COUNT; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; MONOCYTES; NOMOGRAMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SARCOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 84900010587     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28677     Document Type: Article

References (39)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
2. Kattan MW, Leung DH, Brennan MF,. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 2002; 20: 791-6.
3. Hanahan D, Weinberg RA,. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74.
4. Nurden AT,. Platelets, inflammation and tissue regeneration. Thromb Haemost 2011; 105 Suppl 1: S13-33.
5. Coussens LM, Werb Z,. Inflammation and cancer. Nature 2002; 420: 860-7.
6. Mantovani A, Allavena P, Sica A, Balkwill F,. Cancer-related inflammation. Nature 2008; 454: 436-44.
7. Aliustaoglu M, Bilici A, Ustaalioglu BB, Konya V, Gucun M, Seker M, Gumus M,. The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment. Med Oncol 2010; 27: 1060-5.
8. Proctor MJ, McMillan DC, Morrison DS, Fletcher CD, Horgan PG, Clarke SJ,. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer 2012; 107: 695-9.
9. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ,. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005; 91: 181-4.
10. Gwak MS, Choi SJ, Kim JA, Ko JS, Kim TH, Lee SM, Park JA, Kim MH,. Effects of gender on white blood cell populations and neutrophil-lymphocyte ratio following gastrectomy in patients with stomach cancer. J Korean Med Sci 2007; 22 Suppl.: S104-8.
11. Pichler M, Hutterer GC, Stoeckigt C, Chromecki TF, Stojakovic T, Golbeck S, Eberhard K, Gerger A, Mannweiler S, Pummer K, Zigeuner R,. Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients. Br J Cancer 2013; 108: 901-7.
12. Azab B, Shah N, Radbel J, Tan P, Bhatt V, Vonfrolio S, Habeshy A, Picon A, Bloom S,. Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Med Oncol 2013; 30: 432.
13. Smith RA, Bosonnet L, Raraty M, Sutton R, Neoptolemos JP, Campbell F, Ghaneh P,. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg 2009; 197: 466-72.
14. Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Choi HJ, Park KJ, Roh MS, Kim SG, Kim HJ, Lee JH,. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers 2012; 17: 216-22.
15. Porrata LF, Ristow K, Habermann TM, Witzig TE, Colgan JP, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Nowakowski GS, Thompson C, Markovic SN,. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma. Br J Haematol 2012; 157: 321-30.
16. Porrata LF, Ristow K, Colgan JP, Habermann TM, Witzig TE, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Nowakowski GS, Thompson C, Markovic SN,. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma. Haematologica 2012; 97: 262-9.
17. Fletcher CDM,., Bridge JA, Hogendoorn P, Mertens F, eds. WHO classification of tumours of soft tissue and bone, 4th edn., vol. 5. In: WHO Classification of Tumours. Lyon: IARC Press, 2013.
18. Coindre JM,. Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med 2006; 130: 1448-53.
19. Liegl-Atzwanger B, Hofmann G, Leithner A, Beham A,. Undifferentiated high-grade pleomorphic sarcoma (UHPS): Diagnostic criteria, differential diagnosis, and treatment. An attempt to erasure the misnomer MFH. Eur Surg 2009; 41: 143-9.
20. Atzpodien J, Royston P, Wandert T, Reitz M,. DGCIN-German Cooperative Renal Carcinoma Chemo-Immunotherapy Trials Group. Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer 2003; 88: 348-53.
21. Idowu OK, Ding Q, Taktak AF, Chandrasekar CR, Yin Q,. Clinical implication of pretreatment neutrophil to lymphocyte ratio in soft tissue sarcoma. Biomarkers 2012; 17: 539-44.
22. Szkandera J, Absenger G, Liegl-Atzwanger B, Pichler M, Stotz M, Samonigg H, Glehr M, Zacherl M, Stojakovic T, Gerger A, Leithner A,. Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients. Br J Cancer 2013; 108: 1677-83.
23. Altman DG, Royston P,. What do we mean by validating a prognostic model? Stat Med 2000; 19: 453-73.
24. Bleeker SE, Moll HA, Steyerberg EW, Donders AR, Derksen-Lubsen G, Grobbee DE, Moons KG,. External validation is necessary in prediction research: a clinical example. J Clin Epidemiol 2003; 56: 826-32.
25. Li ZM, Huang JJ, Xia Y, et al. Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP. PLoS One 2012; 7: e41658.
26. Schmidt H, Bastholt L, Geertsen P, Christensen IJ, Larsen S, Gehl J, von der Maase H,. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br J Cancer 2005; 93: 273-8.
27. Parkin J, Cohen B,. An overview of the immune system. Lancet 2001; 357: 1777-1789.
28. Delves PJ, Martin SJ, Burton DR, Roitt I, eds. Roitt's essential immunology, 11th edn. Oxford: Blackwell Publishing, 2006. 1-20.
29. Balkwill F,. Cancer and the chemokine network. Nat Rev Cancer 2004; 4: 540-50.
30. Bingle L, Brown NJ, Lewis CE,. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002; 196: 254-65.
31. Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S,. Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 2005; 14: 425-31.
32. Bottazzi B, Polentarutti N, Acero R, Balsari A, Boraschi D, Ghezzi P, Salmona M, Mantovani A,. Regulation of the macrophage content of neoplasms by chemoattractants. Science 1983; 220: 210-2.
33. Mantovani A, Schioppa T, Porta C, Allavena P, Sica A,. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 2006; 25: 315-22.
34. Balkwill F, Mantovani A,. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-45.
35. Lewis CE, Leek R, Harris A, McGee JO,. Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol 1995; 57: 747-51.
36. Coussens LM, Tinkle CL, Hanahan D, Werb Z,. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000; 103: 481-90.
37. Locati M, Deuschle U, Massardi ML, Martinez FO, Sironi M, Sozzani S, Bartfai T, Mantovani A,. Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J Immunol 2002; 168: 3557-62.
38. Sica A, Allavena P, Mantovani A,. Cancer related inflammation: the macrophage connection. Cancer Lett 2008; 267: 204-15.
39. Balkwill F, Charles KA, Mantovani A,. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005; 7: 211-7.